An ATF(24) peptide-functionalized β-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment

Objective: In this study, we aimed to develop an amino-terminal fragment (ATF) peptide-targeted liposome carrying β-elemene (ATF(24)-PEG-Lipo-β-E) for targeted delivery into urokinase plasminogen activator receptor-overexpressing bladder cancer cells combined with cisplatin (DDP) for bladder cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Bingtao, Chen, Peng, Wang, Wengang, Liu, Shuiping, Feng, Jiao, Duan, Ting, Xiang, Yu, Zhang, Ruonan, Zhang, Mingming, Han, Xuemeng, Chen, Xiaying, Li, Qiujie, Li, Guohua, Liu, Ying, Huang, Xingxing, Zhang, Wenzheng, Pan, Ting, Yan, Lili, Jin, Ting, Xie, Tian, Sui, Xinbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476079/
https://www.ncbi.nlm.nih.gov/pubmed/32944399
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476079/
https://www.ncbi.nlm.nih.gov/pubmed/32944399
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0454

Ejemplares similares